Mass Tort brief
Defects, Recalls, and Importer Liability
Product liability settlements in the US and Israel force manufacturers and local importers to pay for systemic product defects.
Mass Tort
Pfizer's $44M Chantix settlement resolves long-running US litigation — ending a major product liability threat that triggered massive parallel recalls for patients in Israel.
BackgroundMultidistrict litigation consolidates thousands of independent product liability lawsuits before a single federal judge to streamline complex pretrial proceedings. Drug manufacturers are legally required to monitor for chemical impurities like nitrosamines, which can form during production and trigger expensive global recalls.
- The settlement resolves claims that Pfizer sold Chantix without disclosing it contained high levels of N-nitroso-varenicline, exposing the pharmaceutical giant to massive legal liabilities.
- Consumers who paid out-of-pocket for Chantix between 2015 and 2021 have until September 14, 2026, to file claims, providing direct financial relief to affected patients.
- In July 2021, the Israeli Ministry of Health, in coordination with Pfizer Israel, initiated a nationwide recall of the drug, aligning local health precautions with international regulatory actions.
Mass Tort
Reversing the dismissal of Teva's lawsuit against Eli Lilly revives a massive generic-competition fight — keeping a lucrative damages path open for the Tel Aviv-listed drug giant.
BackgroundPatent settlements are common legal agreements where generic manufacturers agree to delay their market entry in exchange for ending costly litigation. Brand-name drugmakers are prohibited from taking administrative or regulatory steps to block generic approvals once those agreed dates have passed.
- Teva claims Lilly breached their agreement by taking extra regulatory steps to actively delay FDA approval of Teva’s generic version of the osteoporosis drug Forteo.
- The Seventh Circuit Court of Appeals ruled that Teva's antitrust and breach-of-contract allegations were plausible, reversing a lower court's previous dismissal of the case.
- The ruling revives Teva's legal path to seek substantial financial damages for delayed generic sales after Forteo’s patents expired back in 2019.
Mass Tort
The Chevrolet Malibu settlement establishes a clear local precedent — forcing Israeli vehicle importers to pay for manufacturing flaws even when global automakers do not admit liability.
BackgroundIsraeli class-action laws allow consumers to sue local importers directly for manufacturing defects, holding them financially responsible alongside global manufacturers. Universal Motors Israel operates as the country's exclusive importer and authorized service provider for General Motors vehicles.
- The lawsuit alleged a manufacturing defect in the third brake light allows rainwater to seep into the passenger cabin, damaging interior electronics and upholstery.
- Judge Gilad Lubinsky Ziv approved the compromise settlement, establishing a refund pool for affected vehicle owners without the importer admitting any legal wrongdoing.
- Eligible owners who paid out of pocket to repair the leak during their first 6 years can file refund claims through October 29, 2026, reclaiming their maintenance costs.
Unlock the full brief
Sign in to read every signal, takeaway, and source. Free account — Apple, Google, or email.